Finally someone on that stage said the quiet part about drug pricing negotiations out loud instead of dancing around it.
On cnn.com — see it on the live page
Replies
Price controls on drugs sound great until the pipeline of new treatments dries up because the margin that funded R&D is gone. This has played out before, it's not a hypothetical.